Article | April 29, 2021

The Critical Roles Of cGMP Chemicals And Single-Use Technologies In Cell & Gene Therapy Manufacturing

Source: Avantor

By Tim Korwan, Director, New Product Development, and Wayne Lynch, Senior Product Manager, Avantor

scientist iStock-1166567091
When scaling-up cell and gene therapy manufacturing to production, biomanufacturers may inherently adopt practices from the lab that are inefficient, cost prohibitive, or unpredictable. Two areas of caution are in the use of non-GMP raw materials and small-volume sampling.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Avantor